- $99.43bn
- $118.21bn
- £31.38bn
- 92
- 66
- 99
- 98
REG - GlaxoSmithKline PLC - ViiV/Halozyme sign exclusive licensing agreement
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - GSK and iTeos announce collaboration for EOS-448
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - BMO UK High Inc Tst BMO UK High Inc-BHIB BMO UK High Inc-BHIU - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - GSK recommend ADR holders reject mini-tender offer
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK/Vir Sotrovimab FDA Emergency Use Authorization
AnnouncementREG - GlaxoSmithKline PLC - Sanofi and GSK initiate new Phase 3 clinical study
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK/VIR sotrovimab receives positive EMA opinion
AnnouncementREG - GlaxoSmithKline PLC - Block listing Interim Review
AnnouncementREG - GlaxoSmithKline PLC - Medicago/GSK COVID-19 Vaccine Positive Ph2 Results
AnnouncementREG - GlaxoSmithKline PLC - Sanofi/GSK COVID-19 Vaccine Positive Ph2 Results
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSK Capital PLC - EMTN Prospectus
Announcement